Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes
Official title: Efficacy of Ultrasound-Guided Thoracolumbar Fascia Injection in the Treatment of Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Run by Kanuni Sultan Suleyman Training and Research Hospital · NCT07927530 · Data updated 2026-11-12
This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Kanuni Sultan Suleyman Training and Research Hospital Academic / other |
| Locations | 1 site (Küçükçekmece, Istanbul) |
| Status | Recruiting |
| Started | October 23, 2026 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07927530 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18-65 with type 2 diabetes for at least 1 year and chronic nonspecific low back pain lasting 3 months or more, with focal tenderness over the thoracolumbar fascia and baseline pain of at least 4/10.
✕Probably not a fit
Patients without thoracolumbar fascia tenderness or those with contraindications to injections may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, controlled trial will compare ultrasound-guided thoracolumbar fascia injections plus standard conservative treatment to standard conservative treatment alone in adults aged 18-65 with type 2 diabetes and chronic nonspecific low back pain. Participants will receive injections in addition to education and a structured exercise program, with assessments at baseline, 1 month, and 3 months measuring pain intensity and other outcomes. The study aims to determine if adding the injection provides greater pain relief than standard care alone. Enrollment targets 60 participants across a single center in Istanbul, Turkey. The lead sponsor is Hatice Zehra Ferhatlar, with no listed collaborators.
Why it matters
Potential benefit: If successful, patients may experience greater reductions in back pain and improved function when adding the injection to standard care.
How similar studies have gone: Prior research has explored fascia injections for back pain, but this specific diabetes-related, ultrasound-guided thoracolumbar fascia approach is novel in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
\*\*Inclusion Criteria:\*\* * Age between 18 and 65 years. * Diagnosis of type 2 diabetes mellitus for at least 1 year. * Chronic low back pain lasting at least 3 months. * Nonspecific or mechanical low back pain. * Baseline pain intensity of ≥4 on the Numeric Rating Scale (NRS). * Pain or tenderness on palpation over the thoracolumbar fascia region. * Willingness to participate in the study. * Provision of written informed consent. \*\*Exclusion Criteria:\*\* * Radiculopathy or significant neurological deficits. * Neurogenic claudication due to spinal stenosis. * Spinal tumor or infection. * History or presence of vertebral fracture. * Inflammatory rheumatic disease. * Spinal surgery within the previous 6 months. * Injection in the lumbar region within the previous 3 months. * Anticoagulant therapy or conditions contraindicating injection. * Active infection at the injection site. * Severe systemic disease, including advanced renal failure. * Uncontrolled diabetic metabolic condition. * Pregnancy.
Where it's running
-
Kanuni Sultan Suleyman Training and Research Hospital
Küçükçekmece, Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Hatice Zehra FERHATLAR, MD
- Email: haticezehraferhatlar@gmail.com
- Phone: 05367387869
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Subcutaneous Fat, Back Muscles, and Spine Shape in Back Pain Patients
This study tests whether body fat under the skin and features of back muscles and spine joints are linked to lumbar facet joint degeneration in adults with chronic low back pain.
-
Mulligan Mobilization With Movement for improving ankle movement in type 2 diabetes
This study tests whether Mulligan Mobilization with Movement can improve ankle motion, mobility, pain, and quality of life in people with type 2 diabetes who have limited ankle dorsiflexion.
-
See if serum BDNF levels relate to outcomes in chronic low back pain
This study tests whether blood BDNF levels can help predict how patients with chronic low back pain will do over time.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
-
Palmitoylethanolamide for Central Sensitisation and Neuroinflammation in Chronic Low Back Pain
A treatment with palmitoylethanolamide is being tried to see if it helps people with chronic low back pain who have nerve-related pain and disc problems.
-
Multichannel neuromuscular stimulation plus core exercise for chronic low back pain
This study tests two multichannel neuromuscular electrical stimulation programs added to a core exercise plan to see if they help adults with chronic non-specific low back pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.